Japan Tobacco Inc.

2914

JP3726800000

Tobacco

Delayed Japan Exchange Other stock markets 06:30:00 11/12/2025 GMT			5-day change	1st Jan Change
5,728.00 ^JPY	-1.55%		-0.71%	+40.39%

12-01	Shionogi & Co Completes Acquisition of Japan Tobacco's Pharma Business	MT
12-01	Japan Tobacco Completes Pharmaceutical Business Transfer to Shionogi	MT

Japan Tobacco's Attributable Profit Up 9% in Q1

Published on 05/10/2024 at 01:15 am BST - Modified on 05/10/2024 at 01:16 am BST

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Japan Tobacco Inc.

12-01	Shionogi & Co Completes Acquisition of Japan Tobacco's Pharma Business	MT
12-01	Japan Tobacco Completes Pharmaceutical Business Transfer to Shionogi	MT
11-30	Shionogi & Co., Ltd. completed the acquisition of Pharmaceutical business of Japan Tobacco Inc from Japan Tobacco Inc..	CI
11-25	Japan Tobacco Inc - JT announces new executive appointments	RE
11-06	Jefferies Adjusts Japan Tobacco's Price Target to 5,630 Yen From 4,640 Yen, Keeps at Hold	MT
10-30	Japan Tobacco Inc. Revises Year-End Dividend Guidance for the Fiscal Year Ending December 31, 2025	CI
10-30	Japan Tobacco Inc. Provides Consolidated Earnings Forecasts for the Fiscal Year Ending December 31, 2025	CI
10-30	Japan Tobacco's Nine-Month Profit Climbs 16%	MT
10-30	Japan Tobacco Inc., Q3 2025 Earnings Call, Oct 30, 2025
10-29	Corporate earnings calendar for October 30, 2025: Schneider and TotalEnergies ahead of Amazon and Apple
10-27	Earnings calendar for October 27-31: Apple, Microsoft, Amazon, and others report
09-26	Japan Tobacco Bets on Traditional Cigarettes as Rivals Pursue Smoke-Free Future	MT
09-25	Japan Tobacco Bets on Discount Cigarettes in US as Rivals Push Smokeless	MT
09-24	S&P Rates Japan Tobacco US Subsidiary's Commercial Paper Program A-1	MT
09-05	Japan Tobacco Issues 500 Million Euros Subordinated Bonds	MT
08-31	Torii Pharmaceutical Co., Ltd.'s Equity Buyback announced on May 7, 2025, has expired.	CI
08-31	Shionogi & Co., Ltd. acquired 54.84% stake in Torii Pharmaceutical Co., Ltd. from Japan Tobacco Inc..	CI
08-27	Japan Tobacco Unit Plans Euro Subordinated Bond Issue, Tender Offer for 500 Million Euro Notes	MT
08-25	Japan Tobacco To Receive $1 Billion Dividend From Subsidiary	MT
08-01	Japan's Nikkei slips on tech investment concern; Tokyo Electron plunges	RE
08-01	Japan's Nikkei slips on tech investment concern; Tokyo Electron plunges	RE
08-01	Japan Tobacco Inc., Q2 2025 Earnings Call, Jul 31, 2025
07-31	Powell moves to the front line
07-31	Japan Tobacco Profit Rises 4.8% in H1, Raises Final Dividend Forecast	MT
07-30	Japan Tobacco Inc. Announces Cash Dividend for the Second Quarter End of Fiscal Year Ending December 31, 2025, Payable on September 1, 2025; Revises Dividend Guidance for the Fiscal Year Ending December 31, 2025	CI

Japan Tobacco Inc is a Japan-based company mainly engaged in the tobacco business, the pharmaceutical business and the processed food business. The Company operates through three business segments. The Tobacco segment manufactures and sells manufactured cigarettes in Japan and overseas. The Pharmaceuticals segment is engaged in the research, development, manufacture, and sale of prescription pharmaceuticals. The Processed Foods segment manufactures and sells frozen and room-temperature processed foods and seasonings. In addition, the Company also engages in real estate leasing and other businesses. The Company's tobacco brand portfolio includes the Winston, Camel, Mevius and LD brands.

Employees

53,593

Sector

Tobacco

Calendar

12-28 - Final dividend

More about the company